Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
‘I could eat this podium with a fork and knife I’m so angry’ : Kristen Stewart blasts neglect of female film-makers
5/11/2025
Tell us your experiences of living without a living room
5/11/2025
‘Grim future’ for Great Barrier Reef unless global heating kept to 2C, study finds
5/11/2025
NFL trade deadline : did the bumbling Jets just fleece Jerry Jones and the Cowboys ?
5/11/2025
Fifa heats up battle with players’ union Fifpro by sidelining it from welfare talks
5/11/2025
Crystal Palace charged by FA over fans’ banner of Forest owner Marinakis
5/11/2025